Diesel exposure study of long-lasting inflammation and blood vessels
Part of Heart & circulation clinical trials.
This study exposes healthy adults to diesel fumes to see how it affects inflammation (the body’s response to irritation) and blood vessels over time. It may help researchers understand health risks from diesel air pollution, though it is not for people with existing chronic health conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be generally healthy (not living with chronic illness)
- You must not have heart or circulation disease
- You must not have lung or breathing disease (like asthma or COPD)
- You must not be pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how your immune system (your body’s defense system) reacts to a controlled substance that triggers inflammation. It may help researchers understand why some people have stronger or weaker inflammatory responses.
This trial tests whether regular cannabis use changes how your blood vessels work, compared with people who do not use cannabis. It may help researchers understand potential effects on heart and circulation health.
This study looks at how breathing in wood smoke or traffic pollution affects your health. You'll be exposed to both in a controlled setting, and the results may help understand the risks of air pollution.
This trial studies how immune cells in the lungs respond after ozone exposure, to better understand lung injury. It may help researchers learn what drives inflammation and what could protect the lungs in the future.
This study looks at how common allergens and everyday toxins from things like cleaning products affect your skin, gut, and airways. It may help find ways to prevent or manage allergies and related health issues.
This study tests whether inhaled corticosteroids (a common type of COPD inhaler) can help reduce the harmful effects of air pollution on your lungs. If you have mild to moderate COPD, joining this trial could show how well your current treatment protects you from everyday air pollution.
Hear when a new Atherosclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.